Table 5.
Sr. No. | Compound | Structure | % Inhibition/IC50 | Ref. |
---|---|---|---|---|
24. | 3-((1-Oxoindolin-2-ylidene)methyl)phenyl benzoate | NA | (Kumar et al., 2012) | |
25. | 2-(1H-indol-3-yl) ethylthiourea | 72.6 ± 1.2 μg/mL | (Sanna et al., 2018) | |
26. | 3-(1-Benzyl-5-chloro-2-(ethoxycarbonyl)-4-(trifluoromethyl)-1H-indol-3-yl) propanoic acid | 86.6 μM | (Singh et al., 2020) | |
27. | Indole-3-acetic acid-based inhibitor | 3.9 μM | (Dewangan et al., 2021) | |
28. | Tetracyclic indole derivatives | NA | (Yadav et al., 2015) | |
29. | 4-((3-Acetyl-1-benzyl-2-methyl-1H-indol-5-yl) oxy) butanoic acid | 150 μM | (Sharma et al., 2018) | |
30. | (1-(1-Benzyl-5-((1-(4- bromophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-2-methyl-1H-indol-3-yl) ethanone) | 6.79 μM | (Sharma et al., 2019) |